These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27043280)

  • 1. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.
    Huang M; Liu T; Ma P; Mitteer RA; Zhang Z; Kim HJ; Yeo E; Zhang D; Cai P; Li C; Zhang L; Zhao B; Roccograndi L; O'Rourke DM; Dahmane N; Gong Y; Koumenis C; Fan Y
    J Clin Invest; 2016 May; 126(5):1801-14. PubMed ID: 27043280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering a Key Role of ETS1 on Vascular Abnormality in Glioblastoma.
    Tang J; Li Y; Liu B; Liang W; Hu S; Shi M; Zeng J; Li M; Huang M
    Pathol Oncol Res; 2021; 27():1609997. PubMed ID: 34867089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells.
    Koessinger D; Albrecht V; Faber F; Jaehnert I; Schichor C
    Anticancer Res; 2018 Jun; 38(6):3347-3355. PubMed ID: 29848683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Zeng AL; Yan W; Liu YW; Wang Z; Hu Q; Nie E; Zhou X; Li R; Wang XF; Jiang T; You YP
    Oncogene; 2017 Sep; 36(38):5369-5381. PubMed ID: 28504721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
    Fan Y; Potdar AA; Gong Y; Eswarappa SM; Donnola S; Lathia JD; Hambardzumyan D; Rich JN; Fox PL
    Nat Cell Biol; 2014 May; 16(5):445-56. PubMed ID: 24747440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma.
    Liu T; Ma W; Xu H; Huang M; Zhang D; He Z; Zhang L; Brem S; O'Rourke DM; Gong Y; Mou Y; Zhang Z; Fan Y
    Nat Commun; 2018 Aug; 9(1):3439. PubMed ID: 30150753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEO212, a conjugate of temozolomide and perillyl alcohol, blocks the endothelial-to-mesenchymal transition in tumor-associated brain endothelial cells in glioblastoma.
    Marín-Ramos NI; Jhaveri N; Thein TZ; Fayngor RA; Chen TC; Hofman FM
    Cancer Lett; 2019 Feb; 442():170-180. PubMed ID: 30392789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme.
    Charalambous C; Chen TC; Hofman FM
    Neurosurg Focus; 2006 Apr; 20(4):E22. PubMed ID: 16709028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma.
    Huang M; Zhang D; Wu JY; Xing K; Yeo E; Li C; Zhang L; Holland E; Yao L; Qin L; Binder ZA; O'Rourke DM; Brem S; Koumenis C; Gong Y; Fan Y
    Sci Transl Med; 2020 Feb; 12(532):. PubMed ID: 32102932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device.
    Amemiya T; Hata N; Mizoguchi M; Yokokawa R; Kawamura Y; Hatae R; Sangatsuda Y; Kuga D; Fujioka Y; Takigawa K; Akagi Y; Yoshimoto K; Iihara K; Miura T
    Mol Biol Rep; 2021 Jan; 48(1):395-403. PubMed ID: 33387197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
    J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verbascoside suppresses the migration and invasion of human glioblastoma cells via targeting c-Met-mediated epithelial-mesenchymal transition.
    Hei B; Wang J; Wu G; Ouyang J; Liu RE
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1270-1277. PubMed ID: 31113618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
    Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
    Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Adenosine A₃ Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia.
    Rocha R; Torres Á; Ojeda K; Uribe D; Rocha D; Erices J; Niechi I; Ehrenfeld P; San Martín R; Quezada C
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy.
    Guarnaccia L; Navone SE; Trombetta E; Cordiglieri C; Cherubini A; Crisà FM; Rampini P; Miozzo M; Fontana L; Caroli M; Locatelli M; Riboni L; Campanella R; Marfia G
    Sci Rep; 2018 Jun; 8(1):8748. PubMed ID: 29884885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma.
    Ke C; Luo JR; Cen ZW; Li Y; Cai HP; Wang J; Chen FR; Siegel ER; Le KN; Winokan JR; Gibson GJ; McSwain AE; Afrasiabi K; Linskey ME; Zhou YX; Chen ZP; Zhou YH
    Cancer Sci; 2020 Mar; 111(3):940-950. PubMed ID: 31922633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.